This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gikas, A.
Right arrow Articles by Tselentis, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gikas, A.
Right arrow Articles by Tselentis, Y.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 1998, p. 2747-2748, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

In Vitro Susceptibility of Coxiella burnetii to Trovafloxacin in Comparison with Susceptibilities to Pefloxacin, Ciprofloxacin, Ofloxacin, Doxycycline, and Clarithromycin

Achilleas Gikas,* Ioanna Spyridaki, Anna Psaroulaki, Diamantis Kofterithis, and Yannis Tselentis

Clinical Bacteriology, Parasitology, Zoonoses, and Geographical Medicine, University Hospital of Heraklion, 1352/71110 Crete, Greece

Received 24 April 1998/Returned for modification 28 May 1998/Accepted 16 July 1998

The antibiotic susceptibilities of eight Greek isolates of Coxiella burnetii to trovafloxacin were determined by the shell vial assay. MICs of trovafloxacin and ofloxacin ranged from 1 to 2 µg/ml, those of pefloxacin ranged from 1 to 4 µg/ml, those of ciprofloxacin ranged from 4 to 8 µg/ml, those of doxycycline ranged from 1 to 2 µg/ml, and those of clarithromycin ranged from 2 to 4 µg/ml. Trovafloxacin exhibited no activity against C. burnetii at 4 µg/ml.


* Corresponding author. Mailing address: Clinical Bacteriology, Parasitology, and Geographical Medicine, University Hospital of Heraklion, 1352/71110 Crete, Greece. Phone: 30-81-392360. Fax: 30-81-392847. E-mail: achille{at}edu.uch.gr.


Antimicrobial Agents and Chemotherapy, October 1998, p. 2747-2748, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Spyridaki, I., Psaroulaki, A., Vranakis, I., Tselentis, Y., Gikas, A. (2009). Bacteriostatic and Bactericidal Activities of Tigecycline against Coxiella burnetii and Comparison with Those of Six Other Antibiotics. Antimicrob. Agents Chemother. 53: 2690-2692 [Abstract] [Full Text]  
  • MOROVIC, M. (2005). Q FEVER PNEUMONIA: ARE CLARITHROMYCIN AND MOXIFLOXACIN ALTERNATIVE TREATMENTS ONLY?. Am J Trop Med Hyg 73: 947-948 [Abstract] [Full Text]  
  • Rolain, J.-M., Boulos, A., Mallet, M.-N., Raoult, D. (2005). Correlation between Ratio of Serum Doxycycline Concentration to MIC and Rapid Decline of Antibody Levels during Treatment of Q Fever Endocarditis. Antimicrob. Agents Chemother. 49: 2673-2676 [Abstract] [Full Text]  
  • Raoult, D. (2003). Use of Macrolides for Q Fever. Antimicrob. Agents Chemother. 47: 446-446 [Full Text]  
  • Gikas, A., Kofteridis, D. P., Manios, A., Pediaditis, J., Tselentis, Y. (2001). Newer Macrolides as Empiric Treatment for Acute Q Fever Infection. Antimicrob. Agents Chemother. 45: 3644-3646 [Abstract] [Full Text]  
  • Gikas, A., Spyridaki, I., Scoulica, E., Psaroulaki, A., Tselentis, Y. (2001). In Vitro Susceptibility of Coxiella burnetii to Linezolid in Comparison with Its Susceptibilities to Quinolones, Doxycycline, and Clarithromycin. Antimicrob. Agents Chemother. 45: 3276-3278 [Abstract] [Full Text]  
  • Rolain, J.-M., Maurin, M., Raoult, D. (2001). Bacteriostatic and Bactericidal Activities of Moxifloxacin against Coxiella burnetii. Antimicrob. Agents Chemother. 45: 301-302 [Abstract] [Full Text]